2 hrs ago | Fool.com
Johnson & Johnson Gets Rejected
Remember when it was really uncommon to find the Food and Drug Administration disregarding the advice of its outside experts? For instance, Dendreon 's shares spiked when the advisory-committee panel voted in ...
LOS ANGELES Callaway Golf has chosen independent Eleven as lead creative shop on its $50 million business following a review, the agency said today.
Young Audiences N.J. announces new trustees
Young Audiences New Jersey has announced the appointment of six new members to its board of trustees: Richard Bennett of Princeton, assistant to the president for Capital Projects, Princeton University; Andrea ...
Vertex, J&J to Begin New Telaprevir Study
Vertex Pharmaceuticals VRTX announced Tuesday an agreement with regulators in the U.S. and Europe that greenlights the company and partner Johnson & Johnson JNJ to begin a new phase III study of their ...
Jobs dip 1 percent in NJ pharmaceuticals
Layoffs and restructurings are taking a toll on drug and medical technology companies in New Jersey, one of the state's most important industries.
Foolish Forecast: Taking Medtronic to Heart
There's nothing like getting a medical device approved in the U.S. to really boost a company's earnings.
Serious Money: 'Stable stocks' update - CB, DIS, JNJ, TEVA & XEL
Well, the market was in the dumps yesterday and is even worse today. So this may be a good time to check on my list of stocks for those looking for equities that are stable enough to ride out this bearish ...
Avista Capital Partners Enhances Healthcare Team With Addition of Dr. ...
Avista Capital Partners, a leading private equity firm that invests primarily in growth-oriented healthcare, media, and energy companies, today announced that it has appointed Dr.
Elders pass along lessons in self-reliance to Nanwalek youth
' Irene Tanape recalls speaking only Segtestun while she was growing up in Nanwalek.
Impax sued over generic painkiller
A unit of Johnson & Johnson, the world's largest maker of health-care products, sued generic drugmaker Impax Laboratories Inc.
New Facial Filler Claims To Last Longer Than Others
Carla Sigerseth feels like she is in her 50s but says her face shows the truth. "The lines are really bothering me.
Ortho-McNeil Initiates First-Of-Its-Kind Skin Infection Registry
Main Category: Dermatology Also Included In: Infectious Diseases / Bacteria / Viruses Article Date: 07 Aug 2008 The USA's first, prospective registry of complicated skin and soft tissue infections , known as ...
Paladin Reports 2008 Second Quarter Financial Results
Licensed to Nuvo Research Inc. the exclusive rights to develop and commercialize a novel pain formulation - Entered into a Canadian co-promotion agreement for Seasonale with Procter & Gamble Pharmaceuticals ...
TheWB.com Set for Aug. 27 Launch
'Buffy, the Vampire Slayer' to rise again on TheWB.com. NEW YORK TheWB.com, now in Beta, will launch on Aug.
A drug to treat alcholism, commercialized mainly by Cephalon Inc. in the U.S., received marketing approval in Russia.
Fiery Route 80 crash kills Budd Lake man
ROXBURY -- A 49-year-old Budd Lake mechanic was killed and two others were injured in a fiery five-vehicle crash on Route 80 late Monday night, authorities said.
Vertex on the Verge of Victory
Like the vast majority of biotech drugmakers, Vertex's financials proved less crucial than the clinical trial results from the drugmaker's pipeline.
Income Investor: These Two Stocks Serve As Shelter In Market Storm
In a tough market, most stocks lose ground. Of all the stocks in IBD's database, only 27% were up year to date as of early Monday.
Alkermes Announces Approval of VIVITROL(R) for the Treatment of Alcohol Dependence in Russia
CAMBRIDGE, Mass. - Alkermes, Inc. today announced that its partner, Cilag GmbH International, a subsidiary of Johnson & Johnson, received approval from the Russian Regulatory Authorities to market VIVITROL for ...
Oral Hygiene in the Hong Kong Grew at an Average Rate of 4% between 2001 and 2006
Research and Markets has announced the addition of the "Oral Hygiene in the Hong Kong to 2011" report to their offering.